Production & Manufacturing

Pharmaceutical businesses increasingly outsource their product development and manufacture to Contract Development and manufacture Organizations (CDMOs), which operate in a fragmented sector that is experiencing significant restructuring. However, a lot of CDMOs put their competitiveness at risk by not...

It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to broaden their manufacturing presence in the U.S. so as to lessen the supply chain...

As the U.S. production investments continue to roll in 2025, LTS Lohmann, the German pharmaceutical technology specialist, is joining the table with a deal to boost its CDMO firepower in the U.S. Like many other contract manufacturing expansions that have...

AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the advantages of patients across the U.S. as well as around the world. This $445 million...

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi. Demonstrates Recipharm’s agility and flexibility, completing full tech transfer, scale-up and process optimisation within three months. Strengthens Recipharm’s position as a trusted partner...

Personalized Medicine and the Future of Precision Formulation The medical landscape witnesses a profound transformation as precision formulation personalized medicine reshapes therapeutic paradigms from population-based approaches toward individually tailored interventions. This evolution represents more than incremental improvement in healthcare delivery;...

Advanced Barrier Packaging for Sensitive Biopharmaceuticals The biopharmaceutical industry has experienced unprecedented growth in complex therapeutic products that require sophisticated packaging solutions to maintain their stability, efficacy, and safety throughout distribution and storage. Barrier packaging for biopharmaceuticals has emerged as...